TJRD(600322)
Search documents
津投城开: 华泰联合证券有限责任公司关于天津津投城市开发股份有限公司本次交易相关内幕信息知情人买卖股票情况的自查报告的核查意见
Zheng Quan Zhi Xing· 2025-06-20 13:48
Core Viewpoint - Tianjin Jintou Urban Development Co., Ltd. plans to acquire 100% equity of Tianjin Jinneng Co., Ltd., Tianjin Thermal Power Co., Ltd., and Tianjin Port Yigong Heat Supply Co., Ltd. through asset swaps, share issuance, and cash payments, along with raising supporting funds [1][2]. Group 1: Insider Information and Trading - The self-inspection period for insider trading related to this transaction spans from June 18, 2024, to the day before the disclosure of the restructuring report [1]. - The scope of the insider information includes the company's directors, supervisors, senior management, controlling shareholders, and related parties, as well as intermediaries involved in the transaction [1][2]. Group 2: Trading Activities of Insiders - During the self-inspection period, Tianjin State-owned Capital Investment Operation Co., Ltd., the controlling shareholder, bought 8,649,200 shares and sold 190,186,440 shares of Tianjin Jintou Urban Development Co., Ltd. [2]. - The controlling shareholder stated that the stock trading was part of a plan to increase holdings announced on July 24, 2024, aimed at boosting investor confidence and maintaining market stability [2][3]. Group 3: Individual Insider Trading - A total of 21 individuals engaged in trading activities during the self-inspection period, with various commitments made to ensure that their trading was based on prior announcements and not related to the major asset restructuring [3][4]. - Individuals involved in trading provided assurances that their actions were personal investment decisions and not influenced by insider information regarding the restructuring [4][5]. Group 4: Independent Financial Advisor's Opinion - The independent financial advisor, Huatai United Securities, concluded that the trading activities of the insiders did not constitute insider trading based on the self-inspection reports and commitments provided, and thus do not pose a legal obstacle to the transaction [27][28].
津投城开(600322) - 国联民生证券承销保荐有限公司关于天津津投城市开发股份有限公司本次交易相关内幕信息知情人买卖股票情况的自查报告的核查意见
2025-06-20 12:33
国联民生证券承销保荐有限公司 关于天津津投城市开发股份有限公司本次交易相关内幕信息知 情人买卖股票情况的自查报告的核查意见 天津津投城市开发股份有限公司(以下简称"津投城开"、"上市公司"或"公 司")拟通过资产置换、发行股份及支付现金的方式购买天津津能股份有限公司 (以下简称"津能股份")100%股份、天津市热力有限公司(以下简称"天津热 力")100%股权和天津港益供热有限责任公司(以下简称"港益供热")100%股 权并募集配套资金(以下简称"本次交易"、"本次重组")。 国联民生证券承销保荐有限公司(以下简称"国联民生承销保荐"、"本独立 财务顾问")作为本次交易的独立财务顾问,根据《中华人民共和国证券法》《上 市公司重大资产重组管理办法》《公开发行证券的公司信息披露内容与格式准则 第 26 号——上市公司重大资产重组》《上市公司监管指引第 5 号——上市公司内 幕信息知情人登记管理制度》《监管规则适用指引——上市类第 1 号》《上市公司 监管指引第 7 号——上市公司重大资产重组相关股票异常交易监管》等有关法律 法规及规范性文件的规定,对本次交易相关内幕信息知情人买卖股票情况进行了 核查,具体如下: ...
津投城开(600322) - 北京市金杜律师事务所关于津投城开重大资产重组之内幕信息知情人买卖股票情况自查报告的专项核查意见
2025-06-20 12:33
北京市金杜律师事务所 关于 天津津投城市开发股份有限公司 重大资产置换、发行股份及支付现金购买资产并募集配套资 金暨关联交易 之 内幕信息知情人买卖股票情况自查报告的 专项核查意见 二〇二五年六月 引 言 致:天津津投城市开发股份有限公司 北京市金杜律师事务所(以下简称本所)接受天津津投城市开发股份有限公司 (以下简称津投城开、上市公司或公司)的委托,就公司本次通过资产置换、发行 股份及支付现金方式购买天津津能股份有限公司 100%股份、天津市热力有限公司 100%股权及天津港益供热有限责任公司 100%股权,并募集配套资金暨关联交易 (以下简称本次交易)涉及的相关法律事项,出具本专项核查意见。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司重大资产 重组管理办法(2025 修正)》(中国证券监督管理委员会令第 230 号)、《公开发行 证券的公司信息披露内容与格式准则第 26 号——上市公司重大资产重组(2025 修 正)》(中国证券监督管理委员会公告[2025]5 号)、《监管规则适用指引—上市类第 1 号》等法律、行政法规、部门规章及其他规范性文件的相关规定,本所对本次交 易相关内幕信息 ...
津投城开(600322) - 华泰联合证券有限责任公司关于天津津投城市开发股份有限公司本次交易相关内幕信息知情人买卖股票情况的自查报告的核查意见
2025-06-20 12:33
华泰联合证券有限责任公司 关于天津津投城市开发股份有限公司本次交易相关内幕信息知 情人买卖股票情况的自查报告的核查意见 天津津投城市开发股份有限公司(以下简称"津投城开"、"上市公司"或"公 司")拟通过资产置换、发行股份及支付现金的方式购买天津津能股份有限公司 (以下简称"津能股份")100%股份、天津市热力有限公司(以下简称"天津热 力")100%股权和天津港益供热有限责任公司(以下简称"港益供热")100%股 权并募集配套资金(以下简称"本次交易"、"本次重组")。 华泰联合证券有限责任公司(以下简称"华泰联合证券"、"本独立财务顾问") 作为本次交易的独立财务顾问,根据《中华人民共和国证券法》《上市公司重大 资产重组管理办法》《公开发行证券的公司信息披露内容与格式准则第 26 号—— 上市公司重大资产重组》《上市公司监管指引第 5 号——上市公司内幕信息知情 人登记管理制度》《监管规则适用指引——上市类第 1 号》《上市公司监管指引第 7 号——上市公司重大资产重组相关股票异常交易监管》等有关法律法规及规范 性文件的规定,对本次交易相关内幕信息知情人买卖股票情况进行了核查,具体 如下: 一、本次交易的 ...
津投城开(600322) - 津投城开关于本次交易相关内幕信息知情人买卖股票情况的自查报告的公告
2025-06-20 12:31
证券代码:600322 证券简称:津投城开 公告编号:2025—059 天津津投城市开发股份有限公司 关于本次交易相关内幕信息知情人买卖股票情况的 自查报告的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ●根据中国证券登记结算有限责任公司出具的查询结果,经公司自查、独立 财务顾问和法律顾问核查,相关主体在自查期间买卖津投城开股票的行为不属于 利用内幕信息进行内幕交易的行为,不会对本次交易构成实质性法律障碍。 天津津投城市开发股份有限公司(以下简称"津投城开"、"上市公司"或 "公司")拟通过资产置换、发行股份及支付现金的方式购买天津津能股份有限 公司(以下简称"津能股份")100%股份、天津市热力有限公司(以下简称"天 津热力")100%股权和天津港益供热有限责任公司(以下简称"港益供热") 100%股权并募集配套资金(以下简称"本次交易"、"本次重组")。 (四)标的公司及其董事、监事、高级管理人员及有关知情人员; (五)为本次交易提供服务的相关中介机构及其具体经办人员; (六)前述(一)至(五)项所 ...
津投城开(600322) - 津投城开2025年第四次临时股东大会会议资料
2025-06-16 10:15
证券代码:600322 证券简称:津投城开 天津津投城市开发股份有限公司 2025 年第四次临时股东大会 会 议 资 料 二○二五年六月 目 录 一、天津津投城市开发股份有限公司 2025 年第四次临时股东大会议程 二、关于公司符合重大资产置换、发行股份及支付现金购买资产并募集配套 资金暨关联交易条件的议案 三、关于调整重大资产置换、发行股份及支付现金购买资产并募集配套资金 暨关联交易方案且不构成重大调整的议案 十、关于本次重组符合《上市公司监管指引第 9 号—上市公司筹划和实施重 大资产重组的监管要求》第四条规定的议案 四、关于重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关 联交易方案(调整后)的议案(逐项表决) 五、关于《重大资产置换、发行股份及支付现金购买资产并募集配套资金暨 关联交易报告书(草案)》及其摘要的议案 六、关于签署附生效条件的交易协议的议案 七、关于本次重组构成关联交易的议案 八、关于本次交易预计构成重大资产重组但不构成重组上市的议案 九、关于公司本次重组符合《上市公司重大资产重组管理办法》第十一条、 第四十三条及第四十四条规定的议案 十一、关于本次重组相关主体不存在不得参与任 ...
津投城开推58亿关联重组“退房”转型 注入供热资产净利或增278%达3.75亿
Chang Jiang Shang Bao· 2025-06-16 00:53
Core Viewpoint - The company, Jintou Chengkai, is advancing an asset restructuring plan to transform its business and improve profitability by acquiring high-quality heating assets from its parent company, Tianjin Energy Group, while divesting its real estate development business [1][4]. Group 1: Restructuring Details - Jintou Chengkai plans to acquire 100% equity of three companies: Jinneng Co., Tianjin Thermal, and Gangyi Heating, for a total consideration of 58.62 billion yuan through asset swaps, issuance of shares, and cash payments [1][2]. - The restructuring involves the divestment of its real estate assets and the acquisition of heating assets, marking a strategic shift in its business focus [3][4]. - The company aims to raise up to 500 million yuan in supporting funds, which will be used entirely for cash payments related to the transaction [2]. Group 2: Financial Impact - Post-restructuring, Jintou Chengkai's revenue is projected to increase from 2.712 billion yuan to 3.895 billion yuan, representing a growth of 43.64%, while net profit is expected to rise from a loss of 210 million yuan to a profit of 375 million yuan, a staggering increase of 278.35% [1][7]. - The total asset value and equity attributable to the parent company are expected to grow significantly, with total assets increasing from 13.464 billion yuan to 16.322 billion yuan (21.23% increase) and equity rising from 16.9137 million yuan to 3.975 billion yuan (23,402.57% increase) [7]. - The restructuring is anticipated to alleviate the company's high debt ratio, which stood at 97.76% as of March 2025, thereby enhancing liquidity and risk resilience [7]. Group 3: Market Position and Operations - The three acquired companies will collectively serve 1.24 million households and businesses in Tianjin, covering a heating area of 174 million square meters, which accounts for 29% of the city's total centralized heating area [6]. - The financial performance of the acquired companies indicates strong revenue generation, with Jinneng Co. projected to achieve revenues of 2.977 billion yuan and 3.094 billion yuan in 2023 and 2024, respectively [6].
6月13日晚间重要公告一览
Xi Niu Cai Jing· 2025-06-13 10:43
Group 1 - Company GuoDeWei plans to repurchase shares with a total investment of between 100 million to 150 million yuan, with a maximum repurchase price of 53 yuan per share, expecting to buy back between 1.89 million to 2.83 million shares, accounting for 0.78% to 1.17% of total share capital [1] - Company Shuangliang Energy has won a bid for the Gansu Energy Chemical Qinyang 2×660MW coal power project, with a total bid amount of 237 million yuan, representing 1.82% of the company's projected revenue for 2024 [1] - Company China Pacific Insurance reported a total premium income of 227.17 billion yuan from its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for its life insurance subsidiary and 0.5% for its property insurance subsidiary [1][2] Group 2 - Company LuKang Pharmaceutical has received a drug registration certificate for injectable Cefoperazone Sodium, a third-generation cephalosporin with broad-spectrum antibacterial properties [3] - Company 吉祥航空 reported a 4.97% year-on-year increase in passenger turnover in May, with a seat occupancy rate of 86.14%, up 3.70% year-on-year [4][5] - Company DuRui Pharmaceutical's subsidiary has also received a drug registration certificate for injectable Cefoperazone Sodium [6] Group 3 - Company KeLan Software announced that part of the shares held by its controlling shareholder will be auctioned, involving 5.09 million shares, accounting for 1.07% of the total share capital [7] - Company HuaCan Optoelectronics received a government subsidy of 87.84 million yuan, which is expected to positively impact the company's pre-tax profit for 2025 [8] - Company JinZhi Technology has won a bid for projects from the State Grid and China Resources New Energy, with a total bid amount of 84.41 million yuan [9] Group 4 - Company Vision China completed a capital increase for its subsidiary, raising 100 million yuan to accelerate its layout in the AI field [11] - Company Youa Co. received a profit distribution of 96.03 million yuan from its investment in Changsha Bank [13] - Company WanBangde's subsidiary obtained a patent for a deuterated compound, enhancing the chemical stability and reducing toxicity [16] Group 5 - Company DongCheng Pharmaceutical completed the enrollment of all 488 participants in the Phase III clinical trial for Fluorine-18 PSMA peptide injection, aimed at prostate cancer diagnosis [17] - Company China Merchants Expressway announced that its first phase of medium-term notes for 2024 will pay interest on July 2, 2025, with a total issuance of 2.5 billion yuan and an interest rate of 2.35% [18] - Company JinPu Titanium's subsidiary has temporarily suspended production for maintenance due to falling product prices and high production costs [20] Group 6 - Company BeiLu Pharmaceutical received a marketing authorization for Iodinated Contrast Injection in Hungary, marking another approval in the EU [22] - Company LiXing Co. obtained an overseas investment certificate for its wholly-owned subsidiary in Singapore, with a total investment of 2.16 million yuan [24] - Company LangKun Technology won a garbage collection service project with a bid amount of 21.57 million yuan [26] Group 7 - Company KeRui International plans to transfer 55% of its subsidiary Tianjin ZhiRui's equity for 41.96 million yuan [28] - Company Nanjing JuLong intends to invest 130 million yuan to build a production project for special materials with an annual output of 40,000 tons [30] - Company NanShan Intelligent plans to use up to 50 million yuan of idle funds for cash management in safe and liquid financial products [32] Group 8 - Company GuangLian Aviation completed the business change registration for its subsidiary, involving the introduction of strategic investors [34] - Company XiaoFang Pharmaceutical signed a cooperation agreement to develop a new drug for hair loss treatment [36] - Company GuiZhou SanLi plans to sign a 150 million yuan technology transfer and development contract with Guangdong Pharmaceutical University [38] Group 9 - Company ST SiLong's subsidiary received a drug registration certificate for Famotidine injection, used for treating upper gastrointestinal bleeding [52] - Company ZhongKe Information's executive plans to reduce holdings of up to 180,000 shares, accounting for 0.06% of total share capital [53] - Company KeLun Pharmaceutical's injectable Cefoperazone Sodium/Chloride Sodium injection received drug registration approval [54] Group 10 - Company LuXin Investment plans to transfer 10.06% of its stake in LuXin HuiJin for 203 million yuan, aiming to focus on its main business [56] - Company Western Gold plans to acquire 100% of Xinjiang MeiSheng for 1.655 billion yuan [58] - Company JinTou City Development intends to swap assets worth 5.862 billion yuan, changing its main business to urban centralized heating [60]
津投城开: 津投城开收购报告书摘要
Zheng Quan Zhi Xing· 2025-06-12 11:30
天津津投城市开发股份有限公司 收购报告书摘要 天津津投城市开发股份有限公司 收购报告书摘要 上市公司名称:天津津投城市开发股份有限公司 股票上市地点:上海证券交易所 股票简称:津投城开 股票代码:600322 收购人名称:天津市津能投资有限公司 住所/通讯地址:天津市和平区马场道 142 号增 1 号 一致行动人一名称:天津市燃气集团有限公司 住所/通讯地址:天津市和平区吴家窑二号路 44 号 一致行动人二名称:天津国有资本投资运营有限公司 住所/通讯地址:天津自贸试验区(中心商务区)新华路 3678 号宝风大厦(新 金融大厦) 收购人及其一致行动人声明 一、本报告书摘要系收购人及其一致行动人依据《中华人民共和国公司法》 《中华人民共和国证券法》《上市公司收购管理办法》《公开发行证券的公司信 息披露内容与格式准则第 16 号—上市公司收购报告书》及其他相关的法律、法 规、部门规章及规范性文件的有关规定编制。 二、依据上述法律法规的规定,本报告书摘要已全面披露了收购人及其一致 行动人在天津津投城市开发股份有限公司拥有权益的股份。截至本报告书摘要签 署之日,除本报告书摘要披露的持股信息外,收购人及其一致行动人没有 ...
津投城开(600322) - 津投城开收购报告书摘要
2025-06-12 11:03
天津津投城市开发股份有限公司 收购报告书摘要 天津津投城市开发股份有限公司 收购报告书摘要 上市公司名称:天津津投城市开发股份有限公司 股票上市地点:上海证券交易所 股票简称:津投城开 股票代码:600322 收购人名称:天津市津能投资有限公司 住所/通讯地址:天津市和平区马场道 142 号增 1 号 一致行动人一名称:天津市燃气集团有限公司 住所/通讯地址:天津市和平区吴家窑二号路 44 号 一致行动人二名称:天津国有资本投资运营有限公司 一、本报告书摘要系收购人及其一致行动人依据《中华人民共和国公司法》 《中华人民共和国证券法》《上市公司收购管理办法》《公开发行证券的公司信 息披露内容与格式准则第 16 号—上市公司收购报告书》及其他相关的法律、法 规、部门规章及规范性文件的有关规定编制。 二、依据上述法律法规的规定,本报告书摘要已全面披露了收购人及其一致 行动人在天津津投城市开发股份有限公司拥有权益的股份。截至本报告书摘要签 署之日,除本报告书摘要披露的持股信息外,收购人及其一致行动人没有通过任 何其他方式增加或减少其在天津津投城市开发股份有限公司中拥有权益的股份。 三、收购人及其一致行动人签署本报告书 ...